Precision Medicine

Accelerating Drug Development with Precision

Precision Medicine Capabilities

Alimentiv offers customizable solutions to implement Precision Medicine at any stage of clinical drug development.

box-icon

Scientific Insight & Expert Consulting

more information
box-icon

Translational Lab Services

more information
box-icon

Clinical Pharmacology Services

more information
box-icon

Data Analysis and Interpretation

more information

Precision Medicine: The Alimentiv Advantage

Our deep expertise and experience will help you accelerate drug development with precision

Alimentiv Translational Research Consortium

A global scientific expert team with premier experience

Our collaborative work with leading international specialists and their research teams at major clinical sites provides our clients with access to a network of clinical translational science expertise and services through a single point of contact. A multi-center standardized approach to deliver quantitative and validated state-of-the-art data.

Together, we can gain insights into the pharmacokinetics and pharmacodynamics of compounds in a real-world setting. This will lead to a better understanding of exposure-response relationships, predictors of response, and identification of biomarkers which can be applied to therapeutic regimes in clinical practice or to early drug development.

precision-medicine-thumbnail-min
San Diego
(UCSD)
Los Angeles
(Cedars Sinai)
Toronto
(Mount Sinai)
Rochester
(Mayo Clinic)
Milan
(Humanitas)
Barcelona
(IDIBAPS)
Leuven
(KU Leuven)
Amsterdam
(AMC)

Our Research


Research is at the core of Alimentiv as we drive the science forward to accelerate drug development. We are moving the bench closer to the bedside. The pace of drug development is frequently limited by a lack of necessary resources to translate important findings into actionable results that can inform subsequent clinical studies. We believe translational research should be designed fit-for-purpose and are developing methods to overcome current constraints to the application of translational research in a multi-center clinical trial setting.

Real-World Evidence Studies

Characterizing pharmacokinetic (PK) and pharmacodynamic (PD) parameters of recently approved drugs is important to further understand or identify biomarkers in a real-world patient population.

read more

Sample Procurement, Processing and Storage Methods for Biomarker Analyses

The ability to evaluate predictive and pharmacodynamic biomarkers in a global, multicenter clinical trial is often constrained by factors related to sample collection and processing.

read more

Optimal Biopsy Location for Biomarker Analyses

Where to collect biopsy samples from is a common question in GI-diseases such as Crohn's disease (CD) and Ulcerative Colitis (UC). Standardization of biopsy procurement is essential during drug development to define response to therapy.

read more